FDA
approval
· 2015-09-03
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approves a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)